202 results on '"Quraishi, Mohammed Nabil"'
Search Results
2. Exploring interactions between host and gut microbiota in ulcerative colitis and primary sclerosing cholangitis associated inflammatory bowel disease : an appraisal through faecal microbiota transplantation and systems biology
3. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
4. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
5. Fecal microbiota and volatile metabolome pattern alterations precede late-onset meningitis in preterm neonates
6. Letter: Early real‐world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease
7. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
8. Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again
9. Overview of the second edition of the joint British Society of Gastroenterology and Healthcare Infection Society faecal microbiota transplant guidelines, 2024
10. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
11. The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)
12. Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis
13. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
14. Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis.
15. Noise reduction strategies in metagenomic chromosome confirmation capture to link antibiotic resistance genes to microbial hosts
16. The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
17. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
18. Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer
19. Noise reduction strategies in metagenomic chromosome confirmation capture to link antibiotic resistance genes to microbial hosts
20. Establishing key performance indicators for inflammatory bowel disease in the UK.
21. The growth of faecal microbiota transplantation in the UK: time for a registry?
22. Gut microbiome and autoimmune disorders
23. O7 Investigating IDA: large-scale data showing persistent gaps at the front door
24. P59 The pre-treatment gut microbiome at IBD diagnosis: early insights into the Birmingham inception cohort study
25. P320 Developing an IBD inception pathway: a streamlined pathway to IBD diagnosis in the COVID era
26. The gut-adherent microbiota of PSC–IBD is distinct to that of IBD
27. Sa1883 INCREASED ABUNDANCE AND ACTIVITY OF SUTTERELLA WADSWORTHENSIS AT DISEASE ONSET, ALONGSIDE DEPLETION OF SHORT CHAIN FATTY ACID PRODUCING CLOSTRIDIALES, ASSOCIATES WITH INCREASED USE OF ADVANCED THERAPIES IN THE FIRST TWO YEARS OF IBD DIAGNOSIS.
28. Sa1887 IS DIVERSITY IMPORTANT IN THE GUT MICROBIOME AT IBD ONSET? A SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS OF ALPHA-DIVERSITY DATA
29. Proposed pathway for therapeutic drug monitoring and dose escalation of vedolizumab
30. The gut microbiota and host health: a new clinical frontier
31. Probing the microbiota in PSC: the gut adherent micro-biota of PSC-IBD is distinct to that of IBD and controls: 138
32. SARS-CoV-2-triggered lymphocytic colitis
33. The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era
34. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
35. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice
36. Lack of evidence for the use of ustekinumab for acute severe ulcerative colitis
37. Insight from patients and healthcare professionals on the implementation of virtual clinics in patients with inflammatory bowel disease
38. Breastfeeding promotes early neonatal regulatory T‐cell expansion and immune tolerance of non‐inherited maternal antigens
39. Oral and Intravenous Iron Therapy Differentially Alter The on- and Off-Tumour Microbiota in Anaemic Colorectal Cancer Patients.
40. O9 STOP-colitis pilot: prospective, open-label, randomised study comparing nasogastric versus colonic FMT delivery in ulcerative colitis
41. P136 Immunomodulatory mechanisms of FMT is associated with clinical response in UC – results from STOP-Colitis
42. COVID-19 vaccinations in patients with inflammatory bowel disease
43. Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
44. COVID-19-related health anxieties and impact of specific interventions in patients with inflammatory bowel disease in the UK
45. Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID‐19 in the United Kingdom
46. Letter: faecal microbiota transplantation for IBS
47. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
48. Prevention of COVID-19 in patients with IBD
49. Su1994 ORAL IRON THERAPY PROMOTES A PROINFLAMMATORY GUT MICROBIOTA IN COLORECTAL CANCER PATIENTS WITH IRON DEFICIENCY ANAEMIA
50. Su1995 MICROBIOLOGICAL AND IMMUNOLOGICAL INFLAMMATORY IMMUNE RESPONSES IN ANAEMIC COLORECTAL CANCER PATIENTS TREATED WITH ORAL IRON THERAPY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.